Multimodal treatment of canine osteoarthritis (Sponsored by Hill's and Novartis)
July 1, 2009
By:
Darryl L. Millis, MS, DVM, DACVS, DACVSMR, CCRP
,
Steve Fox, DVM PhD, MBA
,
Michael Reems, DVM, MS, DACVS
,
I. Craig Prior, B.V.Sc.
,
James Roush, DVM, DACVS
,
Robin Downing, DVM, CVA, CCRP, DAAPM
The foundational pieces of multimodal treatment of canine osteoarthritis should include: nonsteroidal anti-inflammatory drugs (NSAIDs), a pet food rich in eicosapentaenoic acid (EPA), and chondroprotective injectable polysulfated glycosaminoglycan (PSGAG). The ultimate goal of a multimodal approach is to provide the maximum quality of extended life with a minimal effective dose of pharmacologics. The optimal multimodal approach is an overlapping of medical and nonmedical management.
|
